Alicia Ault

Drug overdose deaths dropped by 3.1% from 2022, the CDC reports. Despite the overall decline, 15 states reported an increase of up to 44% in overdose deaths.

Research showed a higher incidence of anxiety, depression, and mood disorders among students who had classmates with these disorders.

The centrally acting alpha2-adrenergic agonist allows for nighttime dosing and can be used with stimulants, the drug’s manufacturer says.

As Lykos Therapeutics inches closer to a final decision from the FDA on its MDMA drug for PTSD, questions about the ethics and validity of the company’s clinical trials intensify.

Expert advisers said that midomafetamine held promise but that the trials had too many confounders, making it difficult to determine its true benefits and risks.

Almost one third of physicians who endorsed drugs or devices on X don’t disclose that they receive payments from the company, a new analysis found.

Two new studies reported that a third to almost a half of patients don’t take the medications long enough for clinical benefit.

With mergers and acquisitions in oncology on the rise, community practices are finding ways to maintain their independence.

A single course of treatment with EAET was associated with greater and clinically significant reductions in chronic pain than CBT, the current gold standard.

The dual GIP/GLP-1 agonist is the first drug to show benefit in patients with obstructive sleep apnea.

Two new analyses of the SELECT trial show that the GLP-1 receptor agonist improves cardiovascular health and reduces or normalizes glycemic levels irrespective of baseline A1c.

Two new analyses of the STEP-HFpEF trials show that semaglutide led to more weight loss in women than in men and that the GLP-1 therapy also improves NYHA class.

State surveyors found that CRNAs were practicing beyond their scope at two hospitals in California.

A whistleblower alleged that three cardiothoracic surgeons delegated key aspects of surgery to “unqualified medical residents.”

Investigators also noted continuing disparities in prescribing, with women and Black and Hispanic individuals less likely to get an OUD medication.

Illicit use of the veterinary tranquilizer xylazine continues to spread in the United States. It often fails to respond to the overdose reversal agent naloxone and can cause severe necrotic lesions.

Are CGMs Banned in Olympics for Athletes Without Diabetes?

Pharmaceutical and medical device manufacturers paid cardiology fellows $13.3 million with the majority of the money going to those in procedural intensive subspecialties.

The US Food and Drug Administration has declined to approve MDMA-assisted therapy for the treatment of PTSD.

Two leaders of the controversial Front Line COVID-19 Critical Care Alliance are no longer certified by the American Board of Internal Medicine, ending a 2-year disciplinary process.